Zynex Total Liab from 2010 to 2025

ZYXI Stock  USD 7.92  0.07  0.88%   
Zynex's Total Liabilities is increasing with slightly volatile movements from year to year. Total Liabilities is estimated to finish at about 109.6 M this year. Total Liabilities is the total amount of all liabilities that Zynex Inc has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
1999-06-30
Previous Quarter
89.1 M
Current Value
90.3 M
Quarterly Volatility
23.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zynex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zynex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 M, Interest Expense of 1.3 M or Total Revenue of 222.6 M, as well as many indicators such as Price To Sales Ratio of 2.29, Dividend Yield of 0.0 or PTB Ratio of 9.17. Zynex financial statements analysis is a perfect complement when working with Zynex Valuation or Volatility modules.
  
Check out the analysis of Zynex Correlation against competitors.

Latest Zynex's Total Liab Growth Pattern

Below is the plot of the Total Liab of Zynex Inc over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Zynex's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zynex's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Zynex Total Liab Regression Statistics

Arithmetic Mean31,937,746
Coefficient Of Variation119.67
Mean Deviation31,818,166
Median12,373,000
Standard Deviation38,219,691
Sample Variance1460.7T
Range109.6M
R-Value0.81
Mean Square Error531.9T
R-Squared0.66
Significance0.0001
Slope6,522,359
Total Sum of Squares21911.2T

Zynex Total Liab History

2025109.6 M
2024104.4 M
202390.8 M
202250.1 M
202159.3 M
202015.3 M
20198.6 M

About Zynex Financial Statements

Investors use fundamental indicators, such as Zynex's Total Liab, to determine how well the company is positioned to perform in the future. Although Zynex's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Liabilities104.4 M109.6 M

Currently Active Assets on Macroaxis

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out the analysis of Zynex Correlation against competitors.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.14
Revenue Per Share
5.984
Quarterly Revenue Growth
0.001
Return On Assets
0.0399
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.